Key Details

  • Disclosure made to both BSE Limited and National Stock Exchange of India Ltd
  • Filed on October 28, 2026 at 12:44:16 +05'30'
  • Digitally signed by Sarada Bhamidipati, Company Secretary

Company Background Information

Neuland Laboratories has over 4 decades of experience in API manufacturing through cGMP facilities

  • Operates in close to 80 countries globally
  • Has developed more than 300 processes and 100 APIs
  • Filed approximately 1010+ Regulatory filings across various geographies
  • Maintains 75 active US DMFs (Drug Master Files)

Regulatory Certifications

The company holds multiple international certifications:

  • U.S. FDA
  • TGA (Australia)
  • EDQM (EU)
  • German Health Authority
  • ANVISA (Brazil)
  • EMA (EU)
  • Cofepris (Mexico)
  • KFDA (Korea)
  • PMDA (Japan)
  • CFDA (China)
  • FSI"SID & GP"Russia
  • Health Canada
  • ISO 9001, ISO 14001, OHSAS 18001, and ISO 27001

Additional Information

Company website: www.NeulandLabs.com